The Valley Desk

ArticleJournal for immunotherapy of cancerPublished

Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania, The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
Journal for immunotherapy of cancer
Published
Subject terms
T-Lymphocytes; Cell Line, Tumor; Animals; Mice, Inbred NOD; Humans; Mice; Mice, SCID; Glioblastoma; Brain Neoplasms; Immunotherapy; Xenograft Model Antitumor Assays; Female
PubMed ID
39622583
PubMed Central ID
PMC11624777
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal